电子传递障碍:类固醇生成缺陷与线粒体病的新形式
本文综述类固醇生成障碍的分子机制,重点阐述细胞色素P450氧化还原酶(POR)、细胞色素b5及线粒体电子传递蛋白铁氧还蛋白还原酶(FDXR)和铁氧还蛋白(FDX)缺陷如何导致类固醇生成异常。FDXR突变患者可表现为视力损害、视神经萎缩、神经性耳聋和发育迟缓,并可能伴肾上腺功能不全。
要点
- POR缺陷是罕见的先天性肾上腺 hyperplasia 形式,可致21-羟化酶和17-羟化酶/17,20-裂解酶活性受损。
- P450c17的17,20-裂解酶活性需要POR和细胞色素b5共同促进电子传递。
- FDXR突变患者可表现为视力损害、视神经萎缩、神经性耳聋和发育迟缓,类似线粒体病的全局性神经系统疾病。
核心结论
- FDXR突变可导致线粒体病样神经系统表现,并可能伴肾上腺功能不全。
- 神经科、新生儿科和遗传科医生在评估FDXR突变患者时应寻求内分泌协助。
研究设计与样本
- 综述,总结类固醇生成障碍中电子传递缺陷的相关文献。
主要发现
- POR缺陷患者中,21-羟化酶(P450c21, CYP21A2)和17-羟化酶/17,20-裂解酶(P450c17, CYP17A1)活性受损。
- 严重受影响的POR缺陷个体还患有Antley-Bixler骨骼畸形综合征和两性生殖器发育异常。
- POR、细胞色素b5或P450c17突变可导致选择性17,20-裂解酶缺陷。
- FDXR突变患者表现为视力损害、视神经萎缩、神经性耳聋和发育迟缓,许多患者发生过危及生命的事件或致命感染,常无明确诱因。
- 此类个体中肾上腺功能不全曾被预测但近期才被记录。
临床怎么用
- 神经科、新生儿科和遗传科医生在评估和治疗FDXR突变患者时应寻求内分泌协助。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most disorders of steroidogenesis, such as forms of congenital adrenal hyperplasia (CAH) are caused by mutations in genes encoding the steroidogenic enzymes and are often recognized clinically by cortisol deficiency, hyper- or hypo-androgenism, and/or altered mineralocorticoid function. Most steroidogenic enzymes are forms of cytochrome P450. Most P450s, including several steroidogenic enzymes, are microsomal, requiring electron donation by P450 oxidoreductase (POR); however, several steroidogenic enzymes are mitochondrial P450s, requiring electron donation via ferredoxin reductase (FDXR) and ferredoxin (FDX). POR deficiency is a rare but well-described form of CAH characterized by impaired activity of 21-hydroxylase (P450c21, CYP21A2) and 17-hydroxylase/17,20-lyase (P450c17, CYP17A1); more severely affected individuals also have the Antley-Bixler skeletal malformation syndrome and disordered genital development in both sexes, and hence is easily recognized. The 17,20-lyase activity of P450c17 requires both POR and cytochrome b5 (b5), which promote electron transfer. Mutations of POR, b5, or P450c17 can cause selective 17,20-lyase deficiency. In addition to providing electrons to mitochondrial P450s, FDX, and FDXR are required for the synthesis of iron-sulfur clusters, which are used by many enzymes. Recent work has identified FDXR mutations in patients with visual impairment, optic atrophy, neuropathic hearing loss, and developmental delay, resembling the global neurologic disorders seen with mitochondrial diseases. Many of these patients have had life-threatening events or deadly infections, often without an apparent triggering event. Adrenal insufficiency has been predicted in such individuals but has only been documented recently. Neurologists, neonatologists, and geneticists should seek endocrine assistance in evaluating and treating patients with mutations in FDXR.
引用
- Miller WL, Pandey AV, Flück CE, et al. Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy. J Clin Endocrinol Metab. 2025. PMID: 39574227. doi:10.1210/clinem/dgae815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。